Madrigal Pharmaceuticals last week expanded its portfolio with the acquisition of ervogastat from Pfizer, and AbbVie inked a ...

Japanese drugmakers Mochida Pharmaceutical and Marubeni Pharmaceutical announced that Mochida has obtained new drug approval ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s ...

Effective January1, 2026, STADA Arzneimitel’s global head of communications, Frank Staud, is additionally assuming global ...

WuXi XDC has made a bid to buy fellow Chinese firm BioDlink, a fully integrated CDMO offering end-to-end biologics ...

As many as four decisions under the US Food and Drug Administration’s (FDA) new fast-track program have been delayed, Reuters ...

Japanese drugmaker Tanabe Pharma said its oral candidate dersimelagon met the primary endpoint and showed a favorable safety ...

Eisai has reached a license agreement with Nuvation Bio, a global oncology company focused on tackling some of the toughest ...

Sweden’s Sobi has announced that the European Commission (EC) has approved Aspaveli (pegcetacoplan) for adults and ...

The Danish company Novo Nordisk is trying to stop exports of the Russian generic of Ozempic (semaglutide), which has been ...

Shares of Danish biotech Genmab fell as much as 5% on Friday, after is released disappointing top-line clinical results for ...

US biologics CDMO Avid Bioservices (Nasdaq: CDMO) has appointed Rich McAvoy as chief business officer, as the company talks ...